Faeq Husain-Syed, Ulrike Enke, Friedrich Lübbecke, Winfried Fassbinder, Friedrich Grimminger, Horst-Walter Birk
{"title":"100 Years of Dialysis at University Hospital Giessen.","authors":"Faeq Husain-Syed, Ulrike Enke, Friedrich Lübbecke, Winfried Fassbinder, Friedrich Grimminger, Horst-Walter Birk","doi":"10.1159/000543874","DOIUrl":null,"url":null,"abstract":"<p><p>This review commemorates the 100th anniversary of the first human hemodialysis, which was performed by Georg Haas in 1924 at University Hospital Giessen. Haas' groundbreaking innovation, which included the development of the first functional artificial kidney, laid the foundation for modern hemodialysis therapies. Despite the technical and clinical challenges of his time, Haas' contributions marked a pivotal moment in the history of nephrology. The review also traces the evolution of dialysis at University Hospital Giessen in the decades following Haas' achievements. Key advancements include the introduction of refined hemodialysis technologies, the establishment of a kidney transplant center, an AV Fistula Center, and a regional peritoneal dialysis competence center. Despite these advancements, significant challenges persist worldwide, including the reduced life expectancy of patients undergoing dialysis and global disparities in access to renal replacement therapy. The growing incidence of chronic kidney disease (CKD), which affects 850 million people worldwide, highlights the urgent need for preventive strategies and early interventions. Emerging pharmacological therapies, such as treatment with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists, offer promising opportunities to slow CKD progression and mitigate the associated complications.</p>","PeriodicalId":8953,"journal":{"name":"Blood Purification","volume":" ","pages":"1-19"},"PeriodicalIF":2.2000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Purification","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000543874","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
This review commemorates the 100th anniversary of the first human hemodialysis, which was performed by Georg Haas in 1924 at University Hospital Giessen. Haas' groundbreaking innovation, which included the development of the first functional artificial kidney, laid the foundation for modern hemodialysis therapies. Despite the technical and clinical challenges of his time, Haas' contributions marked a pivotal moment in the history of nephrology. The review also traces the evolution of dialysis at University Hospital Giessen in the decades following Haas' achievements. Key advancements include the introduction of refined hemodialysis technologies, the establishment of a kidney transplant center, an AV Fistula Center, and a regional peritoneal dialysis competence center. Despite these advancements, significant challenges persist worldwide, including the reduced life expectancy of patients undergoing dialysis and global disparities in access to renal replacement therapy. The growing incidence of chronic kidney disease (CKD), which affects 850 million people worldwide, highlights the urgent need for preventive strategies and early interventions. Emerging pharmacological therapies, such as treatment with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists, offer promising opportunities to slow CKD progression and mitigate the associated complications.
期刊介绍:
Practical information on hemodialysis, hemofiltration, peritoneal dialysis and apheresis is featured in this journal. Recognizing the critical importance of equipment and procedures, particular emphasis has been placed on reports, drawn from a wide range of fields, describing technical advances and improvements in methodology. Papers reflect the search for cost-effective solutions which increase not only patient survival but also patient comfort and disease improvement through prevention or correction of undesirable effects. Advances in vascular access and blood anticoagulation, problems associated with exposure of blood to foreign surfaces and acute-care nephrology, including continuous therapies, also receive attention. Nephrologists, internists, intensivists and hospital staff involved in dialysis, apheresis and immunoadsorption for acute and chronic solid organ failure will find this journal useful and informative. ''Blood Purification'' also serves as a platform for multidisciplinary experiences involving nephrologists, cardiologists and critical care physicians in order to expand the level of interaction between different disciplines and specialities.